Monday, January 19, 2026 | 08:45 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 14 - Biocon

Stocks to Watch: IndiGo, Biocon, Pfizer, IEX, TFCI, SAIL, BHEL, Nalco

Indian Energy Exchange and Apollo Pipes have announced their respective record dates for the issuance of bonus shares for eligible shareholders

Stocks to Watch: IndiGo, Biocon, Pfizer, IEX, TFCI, SAIL, BHEL, Nalco
Updated On : 17 Nov 2021 | 8:38 AM IST

Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US

These injections will help control high blood sugar in adult and pediatric patients with type-1 diabetes and adults with type-2

Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
Updated On : 16 Nov 2021 | 11:05 PM IST

Biocon starts campaign to treat diabetic children, train healthcare workers

India has one of the largest populations of children and adolescents living with Type 1 diabetes in the world with an estimated 1 million patients in this age group

Biocon starts campaign to treat diabetic children, train healthcare workers
Updated On : 15 Nov 2021 | 12:09 PM IST

Serum Alliance will give revenue stream from H2FY23: Biocon Biologics exec

In a Q&A, Shreehas Tambe talks about the road ahead for the firm's biosimilars business and how its alliance with Serum is projected to pan out

Serum Alliance will give revenue stream from H2FY23: Biocon Biologics exec
Updated On : 28 Oct 2021 | 10:19 PM IST

Ashok Leyland, Biocon look good on charts for a rebound: Ajit Mishra

The technical analyst from Religare Broking also recommends to accumulate United Spirits. Check out the range below

Ashok Leyland, Biocon look good on charts for a rebound: Ajit Mishra
Updated On : 27 Oct 2021 | 8:32 AM IST

Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr

Revenue growth was primarily driven by good performance of its research services and biosimilars business segments

Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr
Updated On : 22 Oct 2021 | 11:52 AM IST

Sensex slips 336pts; Nifty Bank at new high; RIL falls 3%, TaMo DVR up 10%

Stock market LIVE: The broader markets also ended with notable losses as profit-taking continued for the third straight trading session, amid valuation and inflation concerns

Sensex slips 336pts; Nifty Bank at new high; RIL falls 3%, TaMo DVR up 10%
Updated On : 21 Oct 2021 | 3:49 PM IST

Biocon's insulin biosimilar Glargine gets preference in top US formulary

The USFDA had approved biosimilar Insulin Glargine-yfgn injection (Semglee) as the first interchangeable biosimilar product in July this year

Biocon's insulin biosimilar Glargine gets preference in top US formulary
Updated On : 21 Oct 2021 | 12:19 PM IST

Stocks to Watch: Asian Paints, Biocon, IDBI, JSW Steel, Lodha, TVS Motors

State-run PSU banks and telecom stocks are likely to be in focus along with a slew of mid- and small-cap companies that shall announce their September earnings today

Stocks to Watch: Asian Paints, Biocon, IDBI, JSW Steel, Lodha, TVS Motors
Updated On : 21 Oct 2021 | 8:36 AM IST

Pandora Papers: 'Kunal Kashyap has no influence over Biocon-linked trust'

According to a company statement, the Deanstone Trust, which was mentioned as part of a leak of offshore tax haven files called the 'Pandora Papers,' was set up for philanthropic endeavours

Pandora Papers: 'Kunal Kashyap has no influence over Biocon-linked trust'
Updated On : 06 Oct 2021 | 3:26 AM IST

Decoded: Of 'Pandora Papers', insider trading and Biocon link

Kiran Mazumdar-Shaw, executive chairperson of Biocon denied any impropriety

Decoded: Of 'Pandora Papers', insider trading and Biocon link
Updated On : 05 Oct 2021 | 12:54 AM IST

Allegro Capital named in Pandora Papers: What was the Sebi order about?

Kunal Kashyap's Sebi order was also linked to Biocon. It was related to a 2018 announcement about Biocon's global collaboration with Sandoz

Allegro Capital named in Pandora Papers: What was the Sebi order about?
Updated On : 04 Oct 2021 | 12:55 PM IST

Stocks to watch: ZEEL, Info Edge, NBCC, Biocon, United Breweries, SJVN

State-owned power giant NTPC has bagged 1.9 GW solar projects in CPSU Scheme-II tender

Stocks to watch: ZEEL, Info Edge, NBCC, Biocon, United Breweries, SJVN
Updated On : 27 Sep 2021 | 8:46 AM IST

Biocon Biologics, Serum Institute Life Sciences enter strategic alliance

Work on mRNA platform, antibodies for dengue, HIV in the plan

Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Updated On : 17 Sep 2021 | 10:25 PM IST

Sensex tanks 720 pts from day's high, ends 125 pts down; Nifty PSB drops 3%

On the weekly basis, the benchmark indices gained, thus taking their winning run to the fourth straight week

Sensex tanks 720 pts from day's high, ends 125 pts down; Nifty PSB drops 3%
Updated On : 17 Sep 2021 | 3:40 PM IST

Stocks to watch: Biocon, Hero Moto, Poonawalla Fin, TVS Motor, bank stocks

Hero MotoCorp on Thursday said it will increase the price of its entire model range by up to Rs 3,000 from September 20

Stocks to watch: Biocon, Hero Moto, Poonawalla Fin, TVS Motor, bank stocks
Updated On : 17 Sep 2021 | 9:00 AM IST

Biocon Biologics to offer 15% stake to Serum Institute Life Sciences

Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about $4.9 billion

Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
Updated On : 16 Sep 2021 | 11:40 PM IST

SAT stays Biocon insider trading order

Sebi had directed Allegro Capital and its owner Kunal Kashyap to disgorge Rs 25 lakh for allegedly dealing in shares of Biocon while in possession of price sensitive information.

SAT stays Biocon insider trading order
Updated On : 11 Aug 2021 | 1:50 AM IST

Top headlines: India sticks to growth forecast; Kerala struggles with Covid

Business Standard brings to you the top headlines on Friday

Top headlines: India sticks to growth forecast; Kerala struggles with Covid
Updated On : 30 Jul 2021 | 7:29 AM IST

USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug

Semglee may now be substituted for Sanofi's Lantus by a pharmacist in the US

USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug
Updated On : 30 Jul 2021 | 1:06 AM IST